2016-03-12T00:00:00.000-05:00
Halozyme Therapeutics Inc.,0.58919
analysts,0.44413
Exchange Commission,0.311474
Company MN,0.387392
Creative Planning,0.419552
consensus estimates,0.349071
quarterly earnings results,-0.242506
recent quarter,0.387392
stock,0.370711
email address,0.455228
recent filing,0.311473
related companies,0.58919
InvestorPlace Broker Center,0.555736
high fees,-0.735674
biopharmaceutical company,0.424403
Partners Asset Management,0.315853
personal trading style,0.598412
latest news,0.455228
target price,0.370934
shares,0.423433
concise daily summary,0.455228
consensus target price,0.489286
quarterly revenue,-0.371319
Wells Fargo,0.387392
stock broker,0.245696
consensus rating,0.526131
rating,0.389018
biotechnology company,0.217678
quarter,0.0973627
Halozyme Therapeutics,0.441808
